Jeffrey Cohen, M.D.
| Appointed: |
1994 |
| Gender: |
Male |
| Languages: |
English |
Mellen Center
Biographical Sketch
Jeffrey Cohen, MD, has worked at Cleveland Clinic's Mellen Center for Multiple Sclerosis Treatment and Research since 1994. Dr. Cohen has a large clinical practice devoted primarily to the care of patients with multiple sclerosis and related disorders. In addition, he is Director of the Experimental Therapeutics Program and has been involved in various capacities in a large number of clinical trials developing new therapies for multiple sclerosis.
As Director of the Clinical Neuroimmunology Fellowship, he has trained 13 fellows as of 2007, many of whom have gone on to be prominent in the field. Dr. Cohen has served on a large number grant review committees, advisory groups and national and international task forces. He has over 100 publications concerning immunologic, clinical and research aspects of multiple sclerosis and is frequently invited to speak on these topics.
Professional Highlights
- Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
- Director, Mellen Center Experimental Therapeutics Program
- Director, Mellen Center Clinical Neuroimmunology Fellowship
- Chair, Professional Education Committee, National Multiple Sclerosis Society
Education & Fellowships
| Medical School: | University of Chicago Pritzker School of Medicine, Chicago, IL |
|
| Internship: | Hospital of University of Pennsylvania, Internal Medicine, Philadelphia, PA |
| Residency: | Hospital of University of Pennsylvania, Neurology, Philadelphia, PA |
| Fellowship: | Hospital of University of Pennsylvania, Immunobiology/Neurology, Philadelphia, PA |
| Other Education: | (Undergraduate) Connecticut College, New London, CT |
Certifications
Specialty Interests
Clinical Trials, Multiple Sclerosis, Neuroimmunology.
Innovations & Patents
Cohen JA, Greene MI, Williams WV, Inventors: Method of Stimulating Myelination of Cells, Patent No. 5,219,837.
Awards & Honors
- Freshman Chemistry Award, Connecticut College, 1973
- Sophomore Zoology Award, Connecticut College, 1974
- Junior Zoology Award, Connecticut College, 1975
- Winthrop Scholarship Award, Connecticut College, 1975
- Phi Beta Kappa, Connecticut College, 1976
- Alpha Omega Alpha, University of Chicago, 1980
- Clinician-Investigator Development Award, National Institute of Neurological Disorders and Stroke, 1988
- Distinguished Alumnus, Connecticut College, 1994
- American Neurological Association, 1998
- Health Professional of the Year, Ohio Buckeye Chapter, National Multiple Sclerosis Society, 2001
- Volunteer Hall of Fame, Health Professionals/Researchers, National Multiple Sclerosis Society, 2007
- Best Doctors in America
- Top Doctors, Cleveland Magazine
- America’s Top Doctors, Castle Connolly
Professional Memberships
- American Academy of Neurology
- American Neurological Association
- International Society for Neuroimmunology
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/4/2008, Dr. Cohen has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Cohen receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Biogen Idec
- Genzyme Corporation
- Sanofi-Aventis US Inc.
- Teva Neurosciences, Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
